Key populations brief
Accessed 2017
HIV drug resistance , Users Manual
December 2017
Guidelines
June 2017
HIV strategic information for impact
Moving from accelerated burden reduction to malaria elimination in Zambia
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.12
Key Populations Brief
Accessed November 2017
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
L’OMS a ciblé 17 maladies comme des Maladies Tropicales Négligées. Ces maladies sont très différentes les unes des autres, mais elles ont comme point commun de toucher principalement les populations les plus pauvres. Elles maintiennent dans la pauvreté les populations ayant initialement un n...iveau de développement faible. Ces maladies coexistent au sein des mêmes populations, augmentant de ce fait leur vulnérabilité.
more
Technical Update
HIV Treatment
July 2017
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...ce of antimicrobial resistance in the foodborne bacteria (i.e., bacteria commonly transmitted by food) by taking a One Health approach.
more
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...d over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
more